Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.

AIDS (London, England) - 12 Nov 2008

Poveda Eva, de Mendoza Carmen, Pattery Theresa, González María del Mar, Villacian Jorge, Soriano Vincent

Abstract excerpt

The phenotypic impact on etravirine susceptibility was examined in plasma specimens from 40 nonnucleoside reverse transcriptase inhibitor-experienced HIV patients with distinct nonnucleoside reverse transcriptase inhibitor resistance-associated mutations. Some etravirine resistance-associated mutations produced larger reductions in fold change than others. Y181C in combination with at least one etravirine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Disease Susceptibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Nitriles

Share to Pyridazines

Share to Pyrimidines

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Source

Identifiers

PMID: 18981781
DOI: 10.1097/QAD.0b013e32831692fb

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues.PMID 18981781Read ↗

Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase InhibitorsSemantic proximity Read ↗

Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility.Semantic proximity Read ↗

Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance.Semantic proximity Read ↗

Update of the Drug Resistance Mutations in HIV-1: December 2010Semantic proximity Read ↗

Update of the drug resistance mutations in HIV-1: December 2010.Semantic proximity Read ↗

Short communication prevalence of susceptibility to etravirine by genotype and phenotype in samples received for routine HIV type 1 resistance testing in the United States.Semantic proximity Read ↗

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1Semantic proximity Read ↗

Impact of HIV type 1 drug resistance mutations and phenotypic resistance profile on virologic response to salvage therapy.Semantic proximity Read ↗

Spectrum of Non-Nucleoside Reverse Transcriptase Inhibitor-Associated Drug Resistance Mutations in Persons Living with HIV-1 Receiving Rilpivirine.Semantic proximity Read ↗

Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?Semantic proximity Read ↗

Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility.Semantic proximity Read ↗

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.